Editor(s):

(1) Dr. Koteshwara Mudigonda, Propharmex Company, India.

Reviewers:

(1) Bhagat Baghel, Pandit Deendayal Upadhyay Memorial Health Science & Ayush University of Chattisgarh, India.

(2) Long Niu, First Affiliated Hospital of Dalian Medical University, China.

Additional Reviewers:

(1) Mehmet Kılıç, Fırat University, Turkey.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Bhagat Baghel, India) | File 1 | File 2

Stage 2 | Peer review report_2 (Long Niu, China) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Paola Angelini, University of Perugia, Italy.

Reviewers:

(1) Dinakaran Vasudevan, Kovai Medical Center and Hospital (KMCH), India.

(2) Alexandr Serhiyenko, Danylo Halytsky Lviv National Medical University, Ukraine.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 9.1/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Dinakaran Vasudevan, India) | File 1 | NA

Stage 2 | Peer review report_2 (Alexandr Serhiyenko, Ukraine) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Aurora Martínez Romero, Juarez University, Mexico

Reviewers:

(1) Celso Eduardo Olivier, Instituto Alergoimuno de Americana (Americana’s Allergy and Immunology Institute), Brazil.

(2) Sadandaula Rose Muheriwa Matemba, University of Rochester, USA.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Celso Eduardo Olivier, Brazil) | File 1 | File 2

Stage 2 | Peer review report_2 (Sadandaula Rose Muheriwa Matemba, USA) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Giulio Tarro, Foundation T. & L. de Beaumont Bonelli for cancer Research, Italy.

Reviewers:

(1) Juan Antonio Lugo Machado, Universidad de Sonora, México.

(2) Alma M. Corpuz, Tarlac State Univeristy, Philippines.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.25/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Juan Antonio Lugo Machado, México) | File 1 | File 2

Stage 2 | Peer review report_2 (Alma M. Corpuz, Philippines) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Ana Cláudia Coelho, University of Trás-os-Montes and Alto Douro, Portugal.

Reviewers:

(1) Amal Ali Mukhtad, University of Benghazi, Libya.

(2) Ayatallah Farouk Ahmad Hussein, Cairo University, Egypt.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.75/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Amal Ali Mukhtad, Libya) | File 1 | NA

Stage 2 | Peer review report_2 (Ayatallah Farouk Ahmad Hussein, Egypt) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Juan Carlos Troiano, University of Buenos Aires, Argentina.

Reviewers:

(1) Adeel Khan, Southeast University, China.

(2) Le Thai Van Thanh, University Medical Center, Vietnam.

(3) Abbas Chelobe Mraisel, Missan University, Iraq.

Additional Reviewers:

(1) Cadar Mirela-Emilia, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Romania.

(2) Işın cantekin, Necmettin Erbakan University, Turkey.

(3) Milla Balabanova, “Varna Free University”, Bulgaria.

(4) Darshana Kumari Wankhede, Datta Meghe Institute of Medical Sciences, India.

(5) Pushpendra Kumar, National Institute of Technology Puducherry, India.

(6) Kabyik Goldar, Teerthanker Mahaveer University, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.16/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Adeel Khan, China) | File 1 | NA

Stage 2 | Peer review report_2 (Le Thai Van Thanh, Vietnam) | File 1 | NA

Stage 2 | Peer review report_3 (Abbas Chelobe Mraisel, Iraq) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Dharmesh Chandra Sharma, G.R. Medical College & J. A. Hospital, Gwalior, India.

Reviewers:

(1) Desalegn Feyissa, Mizan – Tepi University, Ethiopia.

(2) Egua Maxwell Osaronowen, University of Abuja, Nigeria.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Desalegn Feyissa, Ethiopia) | File 1 | NA

Stage 2 | Peer review report_2 (Egua Maxwell Osaronowen, Nigeria) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Koteshwara Mudigonda, Propharmex Company, India.

Reviewers:

(1) Kastanis Grigorios, General Hospital of Heraklion Venizelio, Greece.

(2) Seyed Reza Mousavi, Shahid Beheshti University Medical Sciences, Iran.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.25/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Kastanis Grigorios, Greece) | File 1 | NA

Stage 2 | Peer review report_2 (Seyed Reza Mousavi, Iran) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Giuseppe Murdaca, University of Genoa, Italy.

Reviewers:

(1) Samah Nasser Abd El Aziz El Shora, Mansoura University, Egypt.

(2) Heba Kamal Obied, Tanta University, Egypt.

Additional Reviewers:

(1) Wafaa Abdelazeem Elhosany, Suez Canal University, Egypt.

(2) Pritika Basnet, Koshi Health and Science Campus, Nepal.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6.5/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Samah Nasser Abd El Aziz El Shora, Egypt) | File 1 | NA

Stage 2 | Peer review report_2 (Heba Kamal Obied, Egypt) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Ana Cláudia Coelho, University of Trás-os-Montes and Alto Douro, Portugal.

Reviewers:

(1) Hyder Mirghani, University of Tabuk, Saudi Arabia.

(2) Farhanul Huda, All India Institute of Medical Sciences Rishikesh, India.

Additional Reviewers:

(1) Nehan Bahaldden Jafar, Kirkuk University, Iraq.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.75/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Hyder Mirghani, Saudi Arabia) | File 1 | NA

Stage 2 | Peer review report_2 (Farhanul Huda, India) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA